biotech

In a bear market, investors should suit their strategy to their time frame.

New advances in treating common conditions aren’t great news just for those afflicted – they’re also great news for biotech investors.

Remaining objective while investing isn’t just responsible… it’s necessary.

Though biotech used to have a reputation for being volatile, it can actually help defend your portfolio against a recession.

It might be tempting to buy an IPO of a biotech company. But should you?

The cannabis market is exciting… but it can be tough to know which stocks are the real winners.

You can hit some big home runs by investing in the biotech sector… if you handle your risk properly.

Even if you think a company is saving lives or developing the next great drug, make sure you protect yourself and think rationally.

Every January, I head to San Francisco for the Super Bowl of healthcare investing conferences. Here are a few of my takeaways…